These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended September 30, 2013
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from _________ to _________
|
|
Virginia
|
54-1167364
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
o |
Accelerated filer
|
o |
|
Non-accelerated filer
|
o |
Smaller reporting company
|
þ |
|
(Do not check if a smaller reporting company)
|
|
BALANCE SHEETS
|
|
September 30, 2013
|
December 31, 2012
|
|||||||
|
(Unaudited)
|
(see Note 1)
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 2,272,967 | $ | 2,623,016 | ||||
|
Accounts receivable, net
|
2,817,233 | 738,044 | ||||||
|
Prepaid expenses and other current assets
|
639,475 | 191,406 | ||||||
|
Notes receivable, current
|
7,381 | 2,410 | ||||||
|
Total current assets
|
5,737,056 | 3,554,876 | ||||||
|
Property and equipment, net
|
59,687 | 39,226 | ||||||
|
Notes receivable, long-term
|
9,664 | 3,885 | ||||||
|
Other assets
|
6,281 | 6,281 | ||||||
|
Total assets
|
$ | 5,812,688 | $ | 3,604,268 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 2,000,066 | $ | 111,585 | ||||
|
Commissions payable
|
880,776 | 806,133 | ||||||
|
Deferred revenue
|
596,946 | 220,424 | ||||||
|
Accrued payroll and related liabilities
|
210,105 | 269,716 | ||||||
|
Other accrued liabilities
|
45,631 | 48,401 | ||||||
|
Total current liabilities
|
3,733,524 | 1,456,259 | ||||||
|
Stockholders' equity:
|
||||||||
|
Common stock, par value $0.01, 30,000,000 shares authorized;
|
||||||||
|
12,844,376 shares issued, 11,201,760 shares outstanding as of September 30, 2013 and December 31, 2012
|
128,443 | 128,443 | ||||||
|
Additional paid-in capital
|
14,592,923 | 14,581,475 | ||||||
|
Accumulated deficit
|
(11,711,991 | ) | (11,631,698 | ) | ||||
|
Treasury stock, 1,642,616 shares at cost
|
(930,211 | ) | (930,211 | ) | ||||
|
Total stockholders' equity
|
2,079,164 | 2,148,009 | ||||||
|
Total liabilities and stockholders' equity
|
$ | 5,812,688 | $ | 3,604,268 | ||||
|
For the three months ended
|
||||||||
|
September 30
,
|
||||||||
|
2013
|
2012
|
|||||||
|
Revenues:
|
||||||||
|
Professional fees
|
$ | 1,017,243 | $ | 1,363,421 | ||||
|
Software sales
|
2,200,602 | 372,354 | ||||||
|
Total revenues
|
3,217,845 | 1,735,775 | ||||||
|
Cost of revenues:
|
||||||||
|
Cost of professional fees
|
510,397 | 818,926 | ||||||
|
Cost of software sales
|
1,951,931 | 347,011 | ||||||
|
Total cost of revenues
|
2,462,328 | 1,165,937 | ||||||
|
Gross profit
|
755,517 | 569,838 | ||||||
|
Selling, general and administrative expenses
|
371,328 | 388,913 | ||||||
|
Commission expense
|
278,474 | 139,148 | ||||||
|
Income from operations
|
105,715 | 41,777 | ||||||
|
Other income
|
2,652 | 1,645 | ||||||
|
Income before provision for income taxes
|
108,367 | 43,422 | ||||||
|
Provision for income taxes
|
-- | -- | ||||||
|
Net income
|
$ | 108,367 | $ | 43,422 | ||||
|
Comprehensive income
|
$ | 108,367 | $ | 43,422 | ||||
|
Income per common share:
|
||||||||
|
Basic
|
$ | 0.01 | $ | 0.00 | ||||
|
Diluted
|
$ | 0.01 | $ | 0.00 | ||||
|
Weighted average common shares outstanding:
|
||||||||
|
Basic
|
11,201,760 | 11,201,760 | ||||||
|
Diluted
|
11,211,501 | 11,214,921 | ||||||
|
For the nine months ended
|
||||||||
|
September 30
,
|
||||||||
|
2013
|
2012
|
|||||||
|
Revenues:
|
||||||||
|
Professional fees
|
$ | 3,097,139 | $ | 3,891,417 | ||||
|
Software sales
|
2,555,965 | 1,792,939 | ||||||
|
Total revenues
|
5,653,104 | 5,684,356 | ||||||
|
Cost of revenues:
|
||||||||
|
Cost of professional fees
|
1,723,820 | 2,194,556 | ||||||
|
Cost of software sales
|
2,257,318 | 1,670,544 | ||||||
|
Total cost of revenues
|
3,981,138 | 3,865,100 | ||||||
|
Gross profit
|
1,671,966 | 1,819,256 | ||||||
|
Selling, general and administrative expenses
|
1,263,875 | 1,261,325 | ||||||
|
Commission expense
|
494,349 | 490,317 | ||||||
|
(Loss) income from operations
|
(86,258 | ) | 67,614 | |||||
|
Other income
|
5,965 | 4,702 | ||||||
|
(Loss) income before provision for income taxes
|
(80,293 | ) | 72,316 | |||||
|
Provision for income taxes
|
-- | -- | ||||||
|
Net (loss) income
|
$ | (80,293 | ) | $ | 72,316 | |||
|
Comprehensive (loss) income
|
$ | (80,293 | ) | $ | 72,316 | |||
|
(Loss) income per common share:
|
||||||||
|
Basic
|
$ | (0.01 | ) | $ | 0.01 | |||
|
Diluted
|
$ | (0.01 | ) | $ | 0.01 | |||
|
Weighted average common shares outstanding:
|
||||||||
|
Basic
|
11,201,760 | 11,199,442 | ||||||
|
Diluted
|
11,201,760 | 11,213,794 | ||||||
|
STATEMENTS OF CASH FLOWS
|
|
(Unaudited)
|
|
For the nine months ended
September 30,
|
||||||||
|
2013
|
2012
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net (loss) income
|
$ | (80,293 | ) | $ | 72,316 | |||
|
Adjustments to reconcile net (loss) income to
|
||||||||
|
net cash (used in) provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
18,034 | 20,714 | ||||||
|
Stock-based compensation
|
11,448 | 5,197 | ||||||
|
Bad debt expense
|
-- | 1,020 | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(2,079,189 | ) | 1,952,541 | |||||
|
Prepaid expenses and other current assets
|
(448,069 | ) | 629,113 | |||||
|
Accounts payable and accrued expenses
|
1,826,100 | (940,470 | ) | |||||
|
Deferred revenue
|
376,522 | (809,533 | ) | |||||
|
Commissions payable
|
74,643 | 114,950 | ||||||
|
Income taxes
|
-- | (2,800 | ) | |||||
|
Net cash (used in) provided by operating activities
|
(300,804 | ) | 1,043,048 | |||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
(38,495 | ) | (16,359 | ) | ||||
|
Increase in note receivable
|
(14,250 | ) | (10,098 | ) | ||||
|
Payments received on note receivable
|
3,500 | 14,168 | ||||||
|
Net cash used in investing activities
|
(49,245 | ) | (12,289 | ) | ||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from exercise of stock options
|
-- | 350 | ||||||
|
Net cash provided by financing activities
|
-- | 350 | ||||||
|
Net (decrease) increase in cash and cash equivalents
|
(350,049 | ) | 1,031,109 | |||||
|
Cash and cash equivalents, beginning of the period
|
2,623,016 | 1,280,926 | ||||||
|
Cash and cash equivalents, end of the period
|
$ | 2,272,967 | $ | 2,312,035 | ||||
|
Supplemental cash flow information
|
||||||||
|
Interest paid
|
$ | -- | $ | -- | ||||
|
Income taxes paid
|
$ | -- | $ | 2,800 | ||||
|
Three Months ended
September 30,
|
Nine Months ended
September 30,
|
|||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
|||||||||||||
|
Risk free interest rate
|
1.36 | % | n/a | 0.70 – 1.36 | % | 0.75 – 2.31 | % | |||||||||
|
Dividend yield
|
0 | % | n/a | 0 | % | 0 | % | |||||||||
|
Expected term
|
5 years
|
n/a |
5 years
|
5-10 years
|
||||||||||||
|
Expected volatility
|
57.3 | % | n/a | 57.3 - 62.8 | % | 62.8 – 67.9 | % | |||||||||
|
Options outstanding
|
||||||||
|
Number of
shares
|
Weighted average price per share
|
|||||||
|
Balance at December 31, 2012
|
1,032,500 | $ | 0.29 | |||||
|
Options granted
|
160,000 | 0.16 | ||||||
|
Options exercised, expired or forfeited
|
(10,000 | ) | 0.15 | |||||
|
Balance at March 31, 2013
|
1,182,500 | $ | 0.28 | |||||
|
Options granted
|
20,000 | 0.18 | ||||||
|
Options exercised, expired or forfeited
|
(226,000 | ) | 0.22 | |||||
|
Balance at June 30, 2013
|
976,500 | $ | 0.29 | |||||
|
Options granted
|
32,000 | 0.16 | ||||||
|
Options exercised, expired or forfeited
|
(7,500 | ) | 0.19 | |||||
|
Balance at September 30, 2013
|
1,001,000 | $ | 0.29 | |||||
|
Options outstanding
|
||||||||
|
Number of
shares
|
Weighted average price per share
|
|||||||
|
Balance at December 31, 2011
|
1,003,000 | $ | 0.31 | |||||
|
Options granted
|
65,000 | 0.15 | ||||||
|
Options exercised, expired or forfeited
|
(28,000 | ) | 0.36 | |||||
|
Balance at March 31, 2012
|
1,040,000 | $ | 0.30 | |||||
|
Options granted
|
42,500 | 0.15 | ||||||
|
Options exercised
|
(5,000 | ) | 0.07 | |||||
|
Options expired or forfeited
|
(20,000 | ) | 0.20 | |||||
|
Balance at June 30, 2012
|
1,057,500 | $ | 0.29 | |||||
|
Options exercised, expired or forfeited
|
(27,000 | ) | 0.30 | |||||
|
Balance at September 30, 2012
|
1,030,500 | $ | 0.29 | |||||
|
Options outstanding
|
Options exercisable
|
|||||||||||||||||||||||||||||
|
Total shares
|
Weighted average exercise price
|
Weighted average remaining contractual life in years
|
Aggregate
intrinsic value
|
Total shares
|
Weighted average exercise price
|
Weighted average remaining contractual life in years
|
Aggregate
intrinsic value
|
|||||||||||||||||||||||
| 1,001,000 | $ | 0.29 | 5.73 | $ | 3,148 | 765,750 | $ | 0.32 | 4.61 | $ | 2,708 | |||||||||||||||||||
|
Nonvested
|
||||||||
|
Number of
shares
|
Weighted average grant date fair value
|
|||||||
|
Balance at December 31, 2012
|
112,250 | $ | 0.08 | |||||
|
Granted
|
160,000 | 0.08 | ||||||
|
Vested
|
(50,000 | ) | 0.08 | |||||
|
Balance at March 31, 2013
|
222,250 | $ | 0.08 | |||||
|
Granted
|
20,000 | 0.09 | ||||||
|
Vested
|
(39,000 | ) | 0.08 | |||||
|
Balance at June 30, 2013
|
203,250 | $ | 0.08 | |||||
|
Granted
|
32,000 | 0.08 | ||||||
|
Balance at September 30, 2013
|
235,250 | $ | 0.08 | |||||
|
Net
Income
|
Shares |
Per Share
Amount
|
||||||||||
|
Basic net income per common share for the
|
||||||||||||
|
three months ended September 30, 2013:
|
||||||||||||
|
Loss available to common stockholders
|
$ | 108,367 | 11,201,760 | $ | 0.01 | |||||||
|
Effect of dilutive stock options
|
-- | 9,741 | -- | |||||||||
|
Diluted net income per common share for the
|
||||||||||||
|
three months ended September 30, 2013
|
$ | 108,367 | 11,211,501 | $ | 0.01 | |||||||
|
Basic net income per common share for the
|
||||||||||||
|
three months ended September 30, 2012:
|
||||||||||||
|
Income available to common stockholders
|
$ | 43,422 | 11,201,760 | $ | 0.00 | |||||||
|
Effect of dilutive stock options
|
-- | 13,161 | -- | |||||||||
|
Diluted net income per common share for the
|
||||||||||||
|
three months ended September 30, 2012
|
$ | 43,422 | 11,214,921 | $ | 0.00 | |||||||
|
Net
(
Loss) income
|
Shares |
Per Share
Amount
|
||||||||||
|
Basic net loss per common share for the
|
||||||||||||
|
nine months ended September 30, 2013:
|
||||||||||||
|
Loss available to common stockholders
|
$ | ( 80,293 | ) | 11,201,760 | $ | ( 0.01 | ) | |||||
|
Effect of dilutive stock options
|
-- | -- | -- | |||||||||
|
Diluted net loss per common share for the
|
||||||||||||
|
nine months ended September 30, 2013
|
$ | ( 80,293 | ) | 11,201,760 | $ | ( 0.01 | ) | |||||
|
Basic net income per common share for the
|
||||||||||||
|
nine months ended September 30, 2012:
|
||||||||||||
|
Income available to common stockholders
|
$ | 72,316 | 11,199,442 | $ | 0.01 | |||||||
|
Effect of dilutive stock options
|
-- | 14,352 | -- | |||||||||
|
Diluted net income per common share for the
|
||||||||||||
|
nine months ended September 30, 2012
|
$ | 72,316 | 11,213,794 | $ | 0.01 | |||||||
|
·
|
changes in the funding priorities of the U.S. federal government;
|
|
·
|
changes in the way the U.S. federal government contracts with businesses;
|
|
·
|
terms specific to U.S. federal government contracts;
|
|
·
|
our failure to keep pace with a changing technological environment;
|
|
·
|
intense competition from other companies;
|
|
·
|
inaccuracy in our estimates of the cost of services and the timeline for completion of contracts;
|
|
·
|
non-performance by our subcontractors and suppliers;
|
|
·
|
our dependence on key personnel;
|
|
·
|
our dependence on third-party software and software maintenance suppliers;
|
|
·
|
our failure to adequately integrate businesses we may acquire;
|
|
·
|
fluctuations in our results of operations and the resulting impact on our stock price;
|
|
·
|
the exercise of outstanding options;
|
|
·
|
our failure to adequately protect our intellectual property;
|
|
·
|
the limited public market for our common stock; and
|
|
·
|
our forward-looking statements and projections may prove to be inaccurate.
|
|
Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
| Information Analysis Incorporated | |||
| (Registrant) | |||
|
Date:
November 14, 2013
|
By:
|
/S/ Sandor Rosenberg | |
| Sandor Rosenberg, Chairman of the Board, | |||
| Chief Executive Officer, | |||
| and President | |||
| Date: November 14, 2013 | /S/ Richard S. DeRose | ||
| Richard S. DeRose, Executive Vice President, | |||
| Treasurer, and Chief inancial Officer | |||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|